Study of Antibody for Methamphetamine Outpatient Therapy
Status:
Completed
Trial end date:
2021-03-09
Target enrollment:
Participant gender:
Summary
This study evaluates the ability of IXT-m200 to change methamphetamine concentrations in
blood and alter the way methamphetamine feels. Participants will receive either placebo, a
low or high dose of IXT-m200, in addition to methamphetamine challenge doses.